Legislating employee choice in pharmaceutical purchase and delivery is a tricky business.

Experts applaud progress in the battle against opioid abuse, but warn there is more work to be done.

Ironically, opioid pain medications can induce chronic pain rather than suppress it.

A WCRI study shows notably high narcotics use among injured workers in New York and Louisiana.

The success of Texas’ closed formulary for workers’ comp is piquing the interest of other states seeking savings.

High prices and uncertain efficacy make workers’ comp professionals question compound drugs.

Pharmaceuticals can do as much harm as good. Payers can help keep treatments in check.

An injured deli counter clerk abuses her prescription medications.

Experts warn that by 2018 specialty drug costs could rise to 50 percent of total drug costs for workers’ comp payers.

The growing trend of compound drug prescribing raises safety concerns and obscures costs.

More customers benefit from digital risk services from carriers and vendors.

Study connects poor outcomes to early opioid treatment.

New CDC findings on opioid abuse point to need for prescription curbs.

Federal drug laws are woefully outdated.

A flat fee for bill review services would bring transparency to TPA service charges.

Rate cuts for pain management procedures may have repercussions for workers’ comp.

Legislation to regulate group health pharmacy benefit managers could impact workers’ comp payers.

Eight thought leaders in the workers’ comp industry share their top issues of concerns for the coming years.

Florida’s E-Force program is proving effective in reducing prescription-related deaths and overall prescribing volume.

A new report offers guidance for continued efforts to place tight controls on opioid prescribing.